التفاصيل البيبلوغرافية
| العنوان: |
RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas. |
| المؤلفون: |
López-Nieva, Pilar, Fernández-Navarro, Pablo, Vaquero-Lorenzo, Concepción, Villa-Morales, María, Graña-Castro, Osvaldo, Cobos-Fernández, María Ángeles, López-Lorenzo, José Luis, Llamas, Pilar, González-Sanchez, Laura, Sastre, Isabel, Pollan, Marina, Malumbres, Marcos, Santos, Javier, Fernández-Piqueras, José |
| المصدر: |
BMC Cancer; 4/16/2018, Vol. 18 Issue 1, p1-12, 12p, 5 Diagrams, 2 Graphs |
| مصطلحات موضوعية: |
T-cell lymphoma, CYCLIN-dependent kinase inhibitors, RNA sequencing, P53 protein, TRANSCRIPTION factors, HEMATOLOGIC malignancies, THERAPEUTICS, ANIMAL experimentation, CELLULAR signal transduction, COMPARATIVE studies, GENES, LYMPHOBLASTIC leukemia, RESEARCH methodology, MEDICAL cooperation, MICE, PROTEINS, RESEARCH, RESEARCH funding, EVALUATION research, SEQUENCE analysis |
| مستخلص: |
Background: Precursor T-cell lymphoblastic lymphomas (T-LBL) are rare aggressive hematological malignancies that mainly develop in children. As in other cancers, the loss of cell cycle control plays a prominent role in the pathogenesis in these malignancies that is primarily attributed to loss of CDKN2A (encoding protein p16INK4A). However, the impact of the deregulation of other genes such as CDKN1C, E2F1, and TP53 remains to be clarified. Interestingly, experiments in mouse models have proven that conditional T-cell specific deletion of Cdkn1c gene may induce a differentiation block at the DN3 to DN4 transition, and that the loss of this gene in the absence of Tp53 led to aggressive thymic lymphomas.Results: In this manuscript, we demonstrated that the simultaneous deregulation of CDKN1C, E2F1, and TP53 genes by epigenetic mechanisms and/or the deregulation of specific microRNAs, together with additional impairing of TP53 function by the expression of dominant-negative isoforms are common features in primary human T-LBLs.Conclusions: Previous experimental work in mice revealed that T-cell specific deletion of Cdkn1c accelerates lymphomagenesis in the absence of Tp53. If, as expected, the consequences of the deregulation of the CDKN1C-E2F1-TP53 axis were the same as those experimentally demonstrated in mouse models, the disruption of this axis might be useful to predict tumor aggressiveness, and to provide the basis towards the development of potential therapeutic strategiesin human T-LBL. [ABSTRACT FROM AUTHOR] |
|
Copyright of BMC Cancer is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder